Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Serum albumin (ALB), one of the most important proteins in human physiology, has the main functions of maintaining plasma oncotic pressure and plasma volume, transporting hormones, vitamins, oligominerals and drugs, and exerting a powerful antioxidant-anti-inflammatory role. Its prognostic value in liver and malabsorption syndromes is well known. In this narrative review, an analysis of the most important studies evaluating the prognostic significance of low serum ALB levels in hospitalized patients was performed. Specifically, the risk in emergency medicine, cardiovascular diseases, Coronavirus Disease 19 (COVID-19) infection, nephrology, oncology, and autoimmune rheumatic diseases has been examined to fully explore its clinical value. ALB is a negative acute-phase reactant and the reduction in its serum levels represents a threatening parameter for long-term survival in several clinical settings, and a strong biomarker for a poor prognosis in most diseases. Therefore, clinicians should consider serum ALB as a valuable tool to assess the efficacy of specific therapies, both in hospitalized patients and in chronic follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 1×
“Since the majority of immune-mediated inflammatory diseases (IMIDs) are characterized by a down-regulation of serum ALB in response to the inflammatory milieu [88], it is conceivable that its assessment could arise as a useful marker for monitoring the ongoing activity as well as response to treatment.”
BackgroundHotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494 · cited 1×
“In fact, TNF has shown effects on acute phase proteins on its own [31], IL-1 α has been shown to stimulate hepatic synthesis of some proteins up to 1000-fold (serum amyloid A-SAA), and 2–10 fold of fibrinogen, complement components, factor B, metallothionins, but also to decrease the transcription…”
BackgroundGupta, D., & Lis, C. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-69 · Cited by 1,485 · cited 2×
“…[22] CKD hospitalized <2.5 g/dL Mortality, 4.9 fold higher risk [70] Diffuse large B cell lymphoma <3.5 g/dL In-hospital death, 2.0 fold higher [80] HFPEF hospitalized <3.4 g/dL 30 days death, 2.4 fold higher risk [40] CAP hospitalized <3.0 g/dL 30 days mortality, OR: 2.11 [55] COVID-19…”
BackgroundMethodInfluentialThe antioxidant properties of serum albumin
Roche, M., Rondeau, P., Singh, N. R., Tarnus, E., & Bourdon, E. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.057 · Cited by 1,255 · cited 3×
“Modified from “The antioxidant properties of serum albumin” [20].”
BackgroundInfluentialLevitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763 · cited 10×
“Human serum ALB (HSA) is an appealing anti-oxidant molecule [1].”
BackgroundMethodInfluentialNutritional Laboratory Markers in Malnutrition
Keller, U. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060775 · Cited by 753 · cited 2×
“…albumin (and fibrinogen) rates using The study of synthetic fractional albumin (and fibrinogen) rates using simultaneous infusions of intravenous [1-14C] leucine and intraduodenal [4,5-3H] leucine, after 22 h of fasting and, during glucose and amino acids absorption, showed an increase in albumin…”
MethodAnti-inflammatory effects of metformin irrespective of diabetes status
Cameron, A. R., Morrison, V. L., Levin, D., Mohan, M., Forteath, C., Beall, C., McNeilly, A. D., Balfour, D. J. K., Savinko, T., Wong, A. K. F., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308445 · Cited by 704 · cited 1×
“The anti-inflammatory effect of metformin irrespective of diabetes status emphasizes the crucial role that the coexistent antiinflammatory pharmacologic effects on ALB may produce by drugs primarily employed for their specific mechanism of action [69].”
BackgroundRamadori, G., Van Damme, J., Rieder, H., & Zum Büschenfelde, K. M. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180817 · Cited by 284
Straczkowski, M., Dzienis-Straczkowska, S., Stêpieñ, A., Kowalska, I., Szelachowska, M., & Kinalska, I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020135 · Cited by 280
Metadata
- Authors
- Gremese, E., Bruno, D., Varriano, V., Perniola, S., Petricca, L., & Ferraccioli, G.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2023-09-17
- Volume
- 12
- Issue
- 18
- Pages
- 6017
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W4386837158
- Cited by
- 194
- References
- 11
- FWCI
- 20.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.